When a new drug becomes available, prescribers may wish to have independent information to formulate their own opinion about its place in therapy. Information may be in the form of drug monographs or summaries, peer-reviewed articles, clinical guidelines, systematic reviews and clinical evaluations from drug agencies. Knowing where to find information on potential adverse drug reactions is important.
Introduction
Prescribers may feel besieged by information when a new drug is marketed or listed on the Pharmaceutical Benefits Scheme. This information may take the form of glossy brochures, for instance, reports of conference proceedings or presentations at meetings. These publications have often been prepared by the manufacturer, or at least with funding provided by the manufacturer. Prescribers and pharmacists may want to find independent information on a new product.
Some sources of information are freely available online, while others may only be available by subscription or through state health department sites or libraries.
Drug-specific information
Following the registration of a new drug in Australia, the Therapeutic Goods Administration (TGA) publishes the Australian Public Assessment Report (AusPAR) free online (www.tga.gov.au/industry/pm-auspar.htm). This includes information about the clinical evaluation by the TGA, as well as the product information. other national drug agencies provide similar assessments of new drugs online (Table 1) . These are often available before the AusPAR, depending on when the drug is approved overseas, although formulations may differ.
A report of decisions made by the Australian Pharmaceutical Benefits Advisory Committee (PBAC) also becomes available online following its meetings (www.health.gov.au/internet/main/ publishing.nsf/Content/pbac-outcomes-and-public-summarydocuments). once a product is marketed, the approved prescribing information becomes incorporated into practice software systems and is generally available through organisations such as MIMS and Health Communication Network.
Drug summary reports appear in independent publications such as NPS (National Prescribing Service) RADAR and Australian Prescriber ( Table 2 ). Reviews of the product may also be found in other peer-reviewed journals (Table 3 ). There are publications designed for hospital formulary decision makers ( 
Place in therapy
Prescribers may wish to confirm a drug's place in therapy by finding current disease management guidelines or evidencebased reviews.
Australian information
The Therapeutic Guidelines series and the Australian Medicines
Handbook are major sources of information (Table 3 ). However, if any of these particular guidelines are a little dated or do not provide specific information about the drug of interest, it may be necessary to search further. Australian Prescriber and the various other NPS publications such as RADAR also provide guidance on the place of new drugs in therapy and are free ( 
International consensus guidelines and evidence-based reviews

Open access websites
Valuable websites which provide a wide search function for international guidelines and evidence-based reviews include: In my experience, embase generally includes reference to articles more rapidly than Medline. It also has more drug-related search terms than Medline.
Medline and embase require some initial understanding to search them appropriately. A tutorial with a librarian or online is advisable before embarking on serious searching. otherwise searches may be requested via an institutional library or from a local drug information centre.
Information on adverse drug reactions
Clinicians may want to find more information about potential adverse drug reactions. If a particular adverse event is not listed Table 1 ). 
Medicines Safety Update
Reactions Weekly
The journal Reactions Weekly is useful for finding early reports of adverse reactions. This publication scans the literature and a range of other resources broadly. It also includes news from the World Health organization Centre for International Drug Monitoring (Uppsala). Titles for articles can be retrieved free online but payment is required for the full text.
Other sources
Local drug information centres may help with a search for adverse event case reports, including reports in the published literature. These centres often have full access to Reactions
Weekly. Drug companies may also be consulted. They have mandatory requirements to forward adverse event reports to the appropriate authorities.
Telephone services
Local drug information centre phone numbers can be found on the NPS website (www.nps.org.au/health_professionals/guide_ to_medicines_information_resources).
Conclusion
To find useful information about new drugs in a time-efficient manner, it is important to know where valuable information is most likely to be. Understanding how to search online and to make use of resources available through state health department clinical information sites and libraries is fundamental to quick, appropriate drug information retrieval.
